Nanomed Skincare, Inc,headquartered in Cupertino, CA with facility in Suzhou Biobay Innovation Park was established in 2007. The mission of Nanomed Skincare is to provide high quality skin absorption tool to beauty industry. Its proprietary non-invasive skin absorption tool SPE is based on advanced fabrication technology that can reliably produce millions of high-grade nanotips-almost invisible to the naked eye, each with a diameter times 1000 smaller than that of a human hair, to help overcome stratum corneum, the major skin barrier layer.

Nanomed's founders include former employees from the world leader of point-of-care medical device, i-STAT, experienced entrepreneurs and executives, seasoned scientists and engineers, each with more than 20 years of experience in the development and commercialization of advanced technology. Nanomed successfully conducted five full scale human trial for validating the practical utilities of its proprietary Functional MicroArray(FMA) delivery device, leading to CFDA approval of the product. The company successfully completed the Series A institutional funding from Softbank China to support its rapid growth.

Nanomed's business strategy is to focus initially on low hanging fruits such as skincare applications, and offers lower risk and the potential for high return.

Corporate Governance